Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04746911
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 10
Post-approval studies (Phase 4)Study completedNCT03988439
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 16
Not applicableLooking for participantsNCT07243782
What this trial is testing

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

Who this might be right for
Hidradenitis SuppurativaPediatric Plaque PsoriasisJuvenile Idiopathic Arthritis
Novartis Pharmaceuticals 76
Large-scale testing (Phase 3)Study completedNCT01251614
What this trial is testing

A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 114
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT04772079
What this trial is testing

Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 153
Not applicableStudy completedNCT03925441
What this trial is testing

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Who this might be right for
Psoriasis
AbbVie 2
Large-scale testing (Phase 3)Looking for participantsNCT07250802
What this trial is testing

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 110
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Large-scale testing (Phase 3)Study completedNCT04175613
What this trial is testing

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 160
Large-scale testing (Phase 3)Active Not RecruitingNCT05172726
What this trial is testing

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Organon and Co 58
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833307
What this trial is testing

The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis

Who this might be right for
Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 90
Post-approval studies (Phase 4)Study completedNCT02340169
What this trial is testing

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 129
Testing effectiveness (Phase 2)Ended earlyNCT03179605
What this trial is testing

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Who this might be right for
Psoriasis
Primus Pharmaceuticals 22
Post-approval studies (Phase 4)Study completedNCT02186665
What this trial is testing

Plaque Psoriasis Study in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Galderma R&D 19
Large-scale testing (Phase 3)Study completedNCT06088199
What this trial is testing

Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 51
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Not applicableStudy completedNCT05803187
What this trial is testing

Clinical Study of Stage IV Psoriasis in Children With Geleli

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 80
Testing effectiveness (Phase 2)Study completedNCT04655313
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 20
Next Page